Panagora Asset Management Inc Axsome Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $167,289 - $359,741	7,695 Added 60.5%	20,415 $782,000
Q1 2022 May 12, 2022	BUY	$23.7 - $41.39 $301,464 - $526,480	12,720 New	12,720 $526,000
Q4 2020 Feb 10, 2021	SELL	$66.31 - $86.52 $483,466 - $630,817	-7,291 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $242,948 - $305,161	-3,555 Reduced 32.78%	7,291 $519,000
Q2 2020 Aug 12, 2020	BUY	$49.87 - $98.69 $540,890 - $1.07 Million	10,846 New	10,846 $892,000

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.38B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.